Trials / Completed
CompletedNCT04450381
Noninvasive Hemoglobin Testing, Prospective Blood Donors
Noninvasive Hemoglobin Testing in Prospective Blood Donors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 131 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this clinical investigation is to evaluate the pulse oximeter devices for screening prospective blood donors. The purpose study is to report on the accuracy of noninvasive hemoglobin (SpHb) as compared to hemoglobin measurements obtained from a laboratory hematology analyzer in a blood donation setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Rad-67 Pulse oximeter & DCI Mini sensor | Noninvasive pulse oximeter that measures hemoglobin |
Timeline
- Start date
- 2020-06-23
- Primary completion
- 2020-07-07
- Completion
- 2020-07-07
- First posted
- 2020-06-29
- Last updated
- 2021-07-27
- Results posted
- 2021-07-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04450381. Inclusion in this directory is not an endorsement.